4-Pyridoxic Acid

CAS No. 82-82-6

4-Pyridoxic Acid( —— )

Catalog No. M19152 CAS No. 82-82-6

4-Pyridoxic Acid, a catabolite of vitamin B6, is a water-soluble B-group vitamin that can be used as a urinary diagnostic biomarker for determining the nutritional status of these vitamins.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 26 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Pyridoxic Acid
  • Note
    Research use only, not for human use.
  • Brief Description
    4-Pyridoxic Acid, a catabolite of vitamin B6, is a water-soluble B-group vitamin that can be used as a urinary diagnostic biomarker for determining the nutritional status of these vitamins.
  • Description
    4-Pyridoxic Acid, a catabolite of vitamin B6, is a water-soluble B-group vitamin that can be used as a urinary diagnostic biomarker for determining the nutritional status of these vitamins.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    VB6
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    82-82-6
  • Formula Weight
    183.16
  • Molecular Formula
    C8H9NO4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 5 mg/mL (27.30 mMult)
  • SMILES
    CC1=NC=C(C(=C1O)C(=O)O)CO
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Shibata K, et al. Urinary excretion levels of water-soluble vitamins in pregnant and lactating women in Japan[J]. Journal of Nutritional Science & Vitaminology, 2013, 59(3):178-86.
molnova catalog
related products
  • Oxytocin acetate

    Oxytocin is a mammalian neurohypophysial hormone a ligand of oxytocin receptor.

  • ML329

    ML329 is a small molecule inhibitor of MITF, inhibiting TRPM-1 promoter activity.

  • Kira8

    Kira8 is a mono-selective IRE1α inhibitor that allosterically attenuates IRE1α RNase activity (IC50: 5.9 nM).